Identification of suitable endogenous control genes for microRNA expression profiling of childhood medulloblastoma and human neural stem cells

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Genovesi, Laura A ^a   Anderson, Denise ^a   Carter, Kim W ^a   Giles, Keith M ^b   Dallas, Peter B ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Gene expression profiling; Medulloblastoma; MicroRNA; Neural stem cells; Quantitative RT PCR

Indexed keywords

CD133 ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; MICRORNA; PEPTIDE; TUMOR MARKER;

ANALYSIS OF VARIANCE; ARTICLE; CALIBRATION; CELL LINE; CEREBELLUM TUMOR; CHILD; COMPUTER PROGRAM; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; IMMUNOLOGY; INFANT; MALE; MEDULLOBLASTOMA; METABOLISM; METHODOLOGY; MULTICELLULAR SPHEROID; NEURAL STEM CELL; PRESCHOOL CHILD; QUALITY CONTROL; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STANDARD;

ANALYSIS OF VARIANCE; ANTIGENS, CD; CALIBRATION; CELL LINE; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION PROFILING; GLYCOPROTEINS; HUMANS; INFANT; MALE; MEDULLOBLASTOMA; MICRORNAS; NEURAL STEM CELLS; PEPTIDES; QUALITY CONTROL; REAL-TIME POLYMERASE CHAIN REACTION; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOFTWARE; SPHEROIDS, CELLULAR; TUMOR MARKERS, BIOLOGICAL;

EID: 84866150116     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-507     Document Type: Article

References (66)

1. Medulloblastoma, in WHO Classification of Tumours of the Central Nervous System. Giangaspero F, et al. International Agency for Research on Cancer (IARC), Lyon, Louis DN, 2007 132 140
2. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. Thompson MC, et al. J Clin Oncol 2006 24 12 1924 31 10.1200/JCO.2005.04.4974 16567768 (Pubitemid 46638992)
3. Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. Kool M, et al. PLoS One 2008 3 8 3088 10.1371/journal.pone.0003088 18769486
4. Medulloblastoma Comprises Four Distinct Molecular Variants. Northcott PA, et al. J Clin Oncol 2010 29 10 1408 14 20823417
5. Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome. Cho YJ, et al. J Clin Oncol 2011 29 11 1424 30 10.1200/JCO.2010.28.5148 21098324
6. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Kool M, et al. Acta Neuropathol 2012 123 4 473 84 10.1007/s00401-012-0958-8 22358457
7. Cancerous stem cells can arise from pediatric brain tumors. Hemmati HD, et al. Proc Natl Acad Sci USA 2003 100 25 15178 83 10.1073/pnas.2036535100 14645703 (Pubitemid 37518036)
8. Cancer stem cells in nervous system tumors. Singh SK, et al. Oncogene 2004 23 43 7267 73 10.1038/sj.onc.1207946 15378086 (Pubitemid 39382160)
9. Identification of human brain tumour initiating cells. Singh SK, et al. Nature 2004 432 7015 396 401 10.1038/nature03128 15549107 (Pubitemid 39551674)
10. Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas. Sutter R, et al. Oncogene 2010 29 12 1845 56 10.1038/onc.2009.472 20062081
11. An animal model of MYC-driven medulloblastoma. Pei Y, et al. Cancer Cell 2012 21 2 155 67 10.1016/j.ccr.2011.12.021 22340590
12. microRNAs: runts of the genome assert themselves. Lai EC, Curr Bio 2003 13 23 925 936 10.1016/j.cub.2003.11.017 (Pubitemid 37502516)
13. MicroRNAs: genomics, biogenesis, mechanism, and function. Bartel DP, Cell 2004 116 2 281 97 10.1016/S0092-8674(04)00045-5 14744438 (Pubitemid 38167318)
14. Getting to the root of miRNA-mediated gene silencing. Eulalio A, Huntzinger E, Izaurralde E, Cell 2008 132 1 9 14 10.1016/j.cell.2007.12.024 18191211
15. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Filipowicz W, Bhattacharyya SN, Sonenberg N, Nat Rev Genet 2008 9 2 102 14 18197166
16. Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Chekulaeva M, Filipowicz W, Curr Opin Cell Biol 2009 21 3 452 60 10.1016/j.ceb.2009.04.009 19450959
17. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Cheng AM, et al. Nucleic Acids Res 2005 33 4 1290 7 10.1093/nar/gki200 15741182 (Pubitemid 41439922)
18. MicroRNAs and the regulation of cell death. Xu P, Guo M, Hay BA, Trends Genet 2004 20 12 617 24 10.1016/j.tig.2004.09.010 15522457 (Pubitemid 39441280)
19. MicroRNAs modulate hematopoietic lineage differentiation. Chen CZ, et al. Science 2004 303 5654 83 6 10.1126/science.1091903 14657504 (Pubitemid 38055775)
20. MicroRNAs and cancer. Cowland JB, Hother C, Gronbaek K, APMIS 2007 115 10 1090 106 10.1111/j.1600-0463.2007.apm-775.xml.x 18042145 (Pubitemid 350179476)
21. MicroRNAs in Cancer. Garzon R, Calin GA, Croce CM, Annu Rev Med 2009 60 167 79 10.1146/annurev.med.59.053006.104707 19630570
22. MicroRNAs as therapeutic targets in cancer. Nana-Sinkam SP, Croce CM, Transl Res 2011 157 4 216 25 10.1016/j.trsl.2011.01.013 21420032
23. Analytical variables influencing the performance of a miRNA based laboratory assay for prediction of relapse in stage I non-small cell lung cancer (NSCLC). Dahlgaard J, et al. BMC Res Notes 2011 4 424 10.1186/1756-0500-4-424 22011393
24. Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma. Gattolliat CH, et al. Br J Cancer 2011 105 9 1352 1361 10.1038/bjc.2011.388 21970883
25. Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer. Wang ZX, et al. J Surg Oncol 2011 104 7 847 51 10.1002/jso.22008 21721011
26. Prognostic values of the miR-17-92 cluster and its paralogs in colon cancer. Yu G, et al. J Surg Oncol 2012 106 3 232 7 10.1002/jso.22138 22065543
27. A microRNA array reveals extensive regulation of microRNAs during brain development. Krichevsky AM, et al. RNA 2003 9 10 1274 81 10.1261/rna.5980303 13130141 (Pubitemid 37151681)
28. Microarray-based, high-throughput gene expression profiling of microRNAs. Nelson PT, et al. Nat Methods 2004 1 2 155 61 10.1038/nmeth717 15782179
29. A custom microarray platform for analysis of microRNA gene expression. Thomson JM, et al. Nat Methods 2004 1 1 47 53 10.1038/nmeth704 15782152
30. Real-time quantification of microRNAs by stem-loop RT-PCR. Chen C, et al. Nucleic Acids Res 2005 33 20 179 10.1093/nar/gni178 16314309 (Pubitemid 41806407)
31. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Hafner M, et al. Methods 2008 44 1 3 12 10.1016/j.ymeth. 2007.09.009 18158127 (Pubitemid 350297985)
32. How to choose a normalization strategy for miRNA quantitative real-time (qPCR) arrays. Deo A, Carlsson J, Lindlof A, J Bioinform Comput Biol 2011 9 6 795 812 10.1142/S0219720011005793 22084014
33. Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. Peltier HJ, Latham GJ, RNA 2008 14 5 844 52 10.1261/rna.939908 18375788 (Pubitemid 351574906)
34. Housekeeping genes as internal standards: use and limits. Thellin O, et al. J Biotechnol 1999 75 2-3 291 5 10617337 (Pubitemid 29486627)
35. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. Bustin SA, J Mol Endocrinol 2000 25 2 169 93 10.1677/jme.0.0250169 11013345
36. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Vandesompele J, et al. Genome Biol 2002 3 7 ESEARCH0034 RESEARCH0034 12184808
37. Equivalence test in quantitative reverse transcription polymerase chain reaction: confirmation of reference genes suitable for normalization. Haller F, et al. Anal Biochem 2004 335 1 ESEARCH0034 9
38. Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. Davoren PA, et al. BMC Mol Biol 2008 9 76 10.1186/1471-2199-9-76 18718003
39. Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells. Ferretti E, et al. EMBO J 2008 27 19 2616 27 10.1038/emboj.2008.172 18756266
40. The miR-17 92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma. Uziel T, et al. Proc Natl Acad Sci USA 2009 106 8 2812 7 10.1073/pnas.0809579106 19196975
41. MicroRNA profiling in human medulloblastoma. Ferretti E, et al. Int J Cancer 2009 124 3 568 77 10.1002/ijc.23948 18973228
42. MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma. Garzia L, et al. PLoS One 2009 4 3 4998 10.1371/journal.pone.0004998 19308264
43. The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Northcott PA, et al. Cancer Res 2009 69 8 3249 55 10.1158/0008-5472.CAN-08-4710 19351822
44. Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway. Gokhale A, et al. J Cancer Res Ther 2010 6 4 521 9 10.4103/0973-1482.77072 21358093
45. MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence. Venkataraman S, et al. PLoS One 2010 5 6 10748 10.1371/journal.pone.0010748 20574517
46. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Andersen CL, Jensen JL, Orntoft TF, Cancer Res 2004 64 15 5245 50 10.1158/0008-5472.CAN-04- 0496 15289330 (Pubitemid 39006544)
47. Integrated analysis of miRNA and mRNA expression in childhood medulloblastoma compared with neural stem cells. Genovesi LA, et al. PLoS One 2011 6 9 23935 10.1371/journal.pone.0023935 21931624
48. Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma. Schuller U, et al. Cancer Cell 2008 14 2 123 34 10.1016/j.ccr.2008.07.005 18691547
49. Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. Yang ZJ, et al. Cancer Cell 2008 14 2 135 45 10.1016/j.ccr.2008.07.003 18691548
50. Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem. Grammel D, et al. Acta Neuropathol 2012 123 4 601 14 10.1007/s00401-012-0961-0 22349907
51. Subtypes of medulloblastoma have distinct developmental origins. Gibson P, et al. Nature 2010 468 7327 1095 9 10.1038/nature09587 21150899
52. Normalization strategies for microRNA profiling experiments: a 'normal' way to a hidden layer of complexity? Meyer SU, Pfaffl MW, Ulbrich SE, Biotechnol Lett 2010 32 12 1777 88 10.1007/s10529-010-0380-z 20703800
53. A novel and universal method for microRNA RT-qPCR data normalization. Mestdagh P, et al. Genome Biol 2009 10 6 64 10.1186/gb-2009-10-6-r64 19531210
54. MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer. Chang KH, et al. BMC Cancer 2010 10 173 10.1186/1471-2407-10-173 20429937
55. Identification of miR-23a as a novel microRNA normalizer for relative quantification in human uterine cervical tissues. Shen Y, et al. Exp Mol Med 2011 43 6 358 66 10.3858/emm.2011.43.6.039 21519184
56. Identification of reference microRNAs and suitability of archived hemopoietic samples for robust microRNA expression profiling. Viprey VF, Corrias MV, Burchill SA, Anal Biochem 2011 421 2 566 72 22074795
57. Reference genes for the relative quantification of microRNAs in renal cell carcinomas and their metastases. Wotschofsky Z, et al. Anal Biochem 2011 417 2 233 41 10.1016/j.ab.2011.06.009 21741950
58. Suitable reference genes for relative quantification of miRNA expression in prostate cancer. Schaefer A, et al. Exp Mol Med 2010 42 11 749 58 10.3858/emm.2010.42.11.076 20890088
59. The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma. Chen L, et al. J Hepatol 2009 50 2 358 69 19070389
60. Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs. Jensen SG, et al. BMC Genomics 2011 12 435 10.1186/1471-2164-12-435 21867561
61. Systematic evaluation of three microRNA profiling platforms: microarray, beads array, and quantitative real-time PCR array. Wang B, et al. PLoS One 2011 6 2 17167 10.1371/journal.pone.0017167 21347261
62. Isolation, characterization, and differentiation of human embryonic stem cells. Pera MF, et al. Methods Enzymol 2003 365 429 46 14696363 (Pubitemid 37531565)
63. CD133 expression by neural progenitors derived from human embryonic stem cells and its use for their prospective isolation. Peh GS, et al. Stem Cells Dev 2009 18 2 269 82 10.1089/scd.2008.0124 18651819
64. Effective adenovirus-mediated gene transfer into neural stem cells derived from human embryonic stem cells. Bertram CM, et al. Stem Cells Dev 2010 19 4 569 78 10.1089/scd.2009.0183 19594361
65. R: A Language for Data Analysis and Graphics. Ihaka R, Gentleman R, Journal of Computational and Graphical Statistics 1996 5 3 299 314
66. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Livak KJ, Schmittgen TD, Methods 2001 25 4 402 8 10.1006/meth.2001.1262 11846609 (Pubitemid 34164012)